Health Science Journal

Citations : 12326

Health Science Journal received 12326 citations as per Google Scholar report

Indexed In

Genamics JournalSeek
China National Knowledge Infrastructure (CNKI)
CiteFactor
CINAHL Complete
Scimago
Electronic Journals Library
Directory of Research Journal Indexing (DRJI)
EMCare
OCLC- WorldCat
University Grants Commission
Geneva Foundation for Medical Education and Research
Euro Pub
Google Scholar
SHERPA ROMEO
Secret Search Engine Labs

Share This Page

Articles published in Health Science Journal have been cited by esteemed scholars and scientists all around the world. Health Science Journal has got h-index 51, which means every article in Health Science Journal has got 51 average citations.

Following are the list of articles that have cited the articles published in Health Science Journal.

	2022	2021	2020	2019	2018
Year wise published articles	94	177	115	81	68
Year wise citations received	1715	1823	1805	1562	1256

Journal total citations count	12326
Journal Impact Factor	9.13
Journal 5 years impact factor	11.16
Journal CiteScore	10.69
Journal h-index	51

Journal Impact Factor 2020 formula
IF= Citations(y)/{Publications(y-1)+ Publications(y-2)} Y= Year
Journal 5-year Impact Factor 2020 formula
Citations(2016 + 2017 + 2018 + 2019 + 2020)/ {Published articles(2016 + 2017 + 2018 + 2019 + 2020)}
Journal CiteScore
Citescore_y = Citations_y + Citations_y-1 + Citations_y-2 + Citations _y-3 / Published articles_y + Published articles_y-1 + Published articles_y-2 + Published articles _y-3

Important citations

Kim TH, Jung JW, Ha BG, Hong JM, Park EK, et al. (2011) The effects of luteolin on osteoclast differentiation, function in vitro and ovariectomy-induced bone loss. The Journal of nutritional biochemistry 22: 8-15. View at Publisher View at Google Scholar
Liu R, Gao M, Qiang GF, Zhang TT, Lan X, et al. (2009) The anti-amnesic effects of luteolin against amyloid ÃŽÂ² 25Ã¢â‚¬â€œ35 peptide-induced toxicity in mice involve the protection of neurovascular unit. Neuroscience 162: 1232-1243. View at Publisher View at Google Scholar
Kim JA, Kim DK, Kang OH, Choi YA, Park HJ, et al. (2005) Inhibitory effect of luteolin on TNF-ÃŽÂ±-induced IL-8 production in human colon epithelial cells. International immunopharmacology. 5: 209-217. View at Publisher View at Google Scholar
Giacometti A, Cirioni O, Ghiselli R, Mocchegiani F, D'amato G, et al. (2004) Cathelicidin peptide sheep myeloid antimicrobial peptide-29 prevents endotoxin-induced mortality in rat models of septic shock. American journal of respiratory and critical care medicine 169: 187-194. View at Publisher View at Google Scholar
Kim YS, Young MR, Bobe G, Colburn NH, Milner JA (2009) Bioactive food components, inflammatory targets, and cancer prevention. Cancer Prevention Research 2: 200-208. View at Publisher View at Google Scholar
Gerhold K, Bluemchen K, Franke A, Stock P, Hamelmann E (2003) Exposure to endotoxin and allergen in early life and its effect on allergen sensitization in mice. Journal of allergy and clinical immunology. 112: 389-396. View at Publisher View at Google Scholar
Jang S, Dilger RN, Johnson RW (2010) Luteolin inhibits microglia and alters hippocampal-dependent spatial working memory in aged mice. The Journal of nutrition 140: 1892-1898. View at Publisher View at Google Scholar
Lee JK, Kim SY, Kim YS, Lee WH, Hwang DH, et al. (2009) Suppression of the TRIF-dependent signaling pathway of Toll-like receptors by luteolin. Biochemical pharmacology. 77: 1391-1400. View at Publisher View at Google Scholar
Jiang F, Dusting GJ (2003) Natural phenolic compounds as cardiovascular therapeutics: potential role of their antiinflammatory effects. Current vascular pharmacology 1: 135-156. View at Publisher View at Google Scholar
Joh EH, Lee IA, Jung IH, Kim DH (2011) Ginsenoside Rb1 and its metabolite compound K inhibit IRAK-1 activationÃ¢â‚¬â€the key step of inflammation. Biochemical pharmacology 82: 278-286. View at Publisher View at Google Scholar
Adams M, Berset C, Kessler M, Hamburger M (2009) Medicinal herbs for the treatment of rheumatic disordersÃ¢â‚¬â€a survey of European herbals from the 16th and 17th century. Journal of ethnopharmacology 121: 343-359. View at Publisher View at Google Scholar
Kumazawa Y, Kawaguchi K, Takimoto H (2006) Immunomodulating effects of flavonoids on acute and chronic inflammatory responses caused by tumor necrosis factor ÃŽÂ±. Current pharmaceutical design 12: 4271-4279. View at Publisher View at Google Scholar
Xagorari A, Roussos C, Papapetropoulos A (2002) Inhibition of LPSÃ¢â‚¬Âstimulated pathways in macrophages by the flavonoid luteolin. British journal of pharmacology 136: 1058-1064. View at Publisher View at Google Scholar
Choi JS, Choi YJ, Park SH, Kang JS, Kang YH (2004) Flavones mitigate tumor necrosis factor-ÃŽÂ±-induced adhesion molecule upregulation in cultured human endothelial cells: role of nuclear factor-ÃŽÂºB. The Journal of nutrition 134: 1013-1019. View at Publisher View at Google Scholar
Kim JS, Jobin C (2005) The flavonoid luteolin prevents lipopolysaccharideÃ¢â‚¬Âinduced NFÃ¢â‚¬ÂÃŽÂºB signalling and gene expression by blocking IÃŽÂºB kinase activity in intestinal epithelial cells and boneÃ¢â‚¬Âmarrow derived dendritic cells. Immunology 115: 375-387. View at Publisher View at Google Scholar
Shang X, Pan H, Li M, Miao X, Ding H (2011) Lonicera japonica Thunb: ethnopharmacology, phytochemistry and pharmacology of an important traditional Chinese medicine. Journal of ethnopharmacology 138: 1-21. View at Publisher View at Google Scholar
Chen CY, Peng WH, Tsai KD, Hsu SL (2007) Luteolin suppresses inflammation-associated gene expression by blocking NF-ÃŽÂºB and AP-1 activation pathway in mouse alveolar macrophages. Life sciences. 81: 1602-1614. View at Publisher View at Google Scholar
Cazarolli LH, Zanatta L, Alberton EH, Figueiredo B, Reis MS, et al. (2008) Flavonoids: prospective drug candidates. Mini reviews in medicinal chemistry 8: 1429-1440. View at Publisher View at Google Scholar
Seelinger G, Merfort I, Schempp CM (2008). Anti-oxidant, anti-inflammatory and anti-allergic activities of luteolin. Planta medica 74: 1667-1677. View at Publisher View at Google Scholar
Lin Y, Shi R, Wang X, Shen HM (2008) Luteolin, a flavonoid with potential for cancer prevention and therapy. Current cancer drug targets 8: 634-646. View at Publisher View at Google Scholar
Prev 1 2 ... 32 33 34 35 36 37 38 39 40 41 42 43 44 Next »

Google Scholar citation report

Citations : 12326

Indexed In

Share This Page

Important citations

Kim TH, Jung JW, Ha BG, Hong JM, Park EK, et al. (2011) The effects of luteolin on osteoclast differentiation, function in vitro and ovariectomy-induced bone loss. The Journal of nutritional biochemistry 22: 8-15.

Liu R, Gao M, Qiang GF, Zhang TT, Lan X, et al. (2009) The anti-amnesic effects of luteolin against amyloid ÃŽÂ² 25Ã¢â‚¬â€œ35 peptide-induced toxicity in mice involve the protection of neurovascular unit. Neuroscience 162: 1232-1243.

Kim JA, Kim DK, Kang OH, Choi YA, Park HJ, et al. (2005) Inhibitory effect of luteolin on TNF-ÃŽÂ±-induced IL-8 production in human colon epithelial cells. International immunopharmacology. 5: 209-217.

Giacometti A, Cirioni O, Ghiselli R, Mocchegiani F, D'amato G, et al. (2004) Cathelicidin peptide sheep myeloid antimicrobial peptide-29 prevents endotoxin-induced mortality in rat models of septic shock. American journal of respiratory and critical care medicine 169: 187-194.

Kim YS, Young MR, Bobe G, Colburn NH, Milner JA (2009) Bioactive food components, inflammatory targets, and cancer prevention. Cancer Prevention Research 2: 200-208.

Gerhold K, Bluemchen K, Franke A, Stock P, Hamelmann E (2003) Exposure to endotoxin and allergen in early life and its effect on allergen sensitization in mice. Journal of allergy and clinical immunology. 112: 389-396.

Jang S, Dilger RN, Johnson RW (2010) Luteolin inhibits microglia and alters hippocampal-dependent spatial working memory in aged mice. The Journal of nutrition 140: 1892-1898.

Lee JK, Kim SY, Kim YS, Lee WH, Hwang DH, et al. (2009) Suppression of the TRIF-dependent signaling pathway of Toll-like receptors by luteolin. Biochemical pharmacology. 77: 1391-1400.

Jiang F, Dusting GJ (2003) Natural phenolic compounds as cardiovascular therapeutics: potential role of their antiinflammatory effects. Current vascular pharmacology 1: 135-156.

Joh EH, Lee IA, Jung IH, Kim DH (2011) Ginsenoside Rb1 and its metabolite compound K inhibit IRAK-1 activationÃ¢â‚¬â€the key step of inflammation. Biochemical pharmacology 82: 278-286.

Adams M, Berset C, Kessler M, Hamburger M (2009) Medicinal herbs for the treatment of rheumatic disordersÃ¢â‚¬â€a survey of European herbals from the 16th and 17th century. Journal of ethnopharmacology 121: 343-359.

Kumazawa Y, Kawaguchi K, Takimoto H (2006) Immunomodulating effects of flavonoids on acute and chronic inflammatory responses caused by tumor necrosis factor ÃŽÂ±. Current pharmaceutical design 12: 4271-4279.

Xagorari A, Roussos C, Papapetropoulos A (2002) Inhibition of LPSÃ¢â‚¬Âstimulated pathways in macrophages by the flavonoid luteolin. British journal of pharmacology 136: 1058-1064.

Choi JS, Choi YJ, Park SH, Kang JS, Kang YH (2004) Flavones mitigate tumor necrosis factor-ÃŽÂ±-induced adhesion molecule upregulation in cultured human endothelial cells: role of nuclear factor-ÃŽÂºB. The Journal of nutrition 134: 1013-1019.

Shang X, Pan H, Li M, Miao X, Ding H (2011) Lonicera japonica Thunb: ethnopharmacology, phytochemistry and pharmacology of an important traditional Chinese medicine. Journal of ethnopharmacology 138: 1-21.

Chen CY, Peng WH, Tsai KD, Hsu SL (2007) Luteolin suppresses inflammation-associated gene expression by blocking NF-ÃŽÂºB and AP-1 activation pathway in mouse alveolar macrophages. Life sciences. 81: 1602-1614.

Cazarolli LH, Zanatta L, Alberton EH, Figueiredo B, Reis MS, et al. (2008) Flavonoids: prospective drug candidates. Mini reviews in medicinal chemistry 8: 1429-1440.

Seelinger G, Merfort I, Schempp CM (2008). Anti-oxidant, anti-inflammatory and anti-allergic activities of luteolin. Planta medica 74: 1667-1677.

Lin Y, Shi R, Wang X, Shen HM (2008) Luteolin, a flavonoid with potential for cancer prevention and therapy. Current cancer drug targets 8: 634-646.

Joh EH, Lee IA, Jung IH, Kim DH (2011) Ginsenoside Rb1 and its metabolite compound K inhibit IRAK-1 activationÃ¢â‚¬â€the key step of inflammation. Biochemical pharmacology 82: 278-286.

Adams M, Berset C, Kessler M, Hamburger M (2009) Medicinal herbs for the treatment of rheumatic disordersÃ¢â‚¬â€a survey of European herbals from the 16th and 17th century. Journal of ethnopharmacology 121: 343-359.

Xagorari A, Roussos C, Papapetropoulos A (2002) Inhibition of LPSÃ¢â‚¬Âstimulated pathways in macrophages by the flavonoid luteolin. British journal of pharmacology 136: 1058-1064.